bit.bio Launches ioTracker Cells Range at SLAS 2025, Adding New Visualisation Functionality to Human iPSC-derived Cell Types

Researchers can easily track and isolate bit.bio’s consistent, defined, and scalable human iPSC-derived cells for the first time, opening up new applications in neurodegenerative drug discovery. ioTracker Cells, the new range within bit.bio’s ioCells portfolio, deliver added visualisation…